— Know what they know.
/
Not Investment Advice

PBYI NASDAQ

Puma Biotechnology, Inc.
1W: +1.5% 1M: +11.2% 3M: +39.8% YTD: +89.2% 1Y: +108.8% 3Y: +374.8% 5Y: +84.2%
$10.92
+0.07 (+0.65%)
After Hours: $11.38 (+0.46, +4.26%)
Weekly Expected Move ±6.4%
$10 $10 $11 $12 $12
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Buy · Power 72 · $563.7M mcap · 40M float · 0.866% daily turnover · Short 70% of daily vol
Credit Risk of going bust: lower than 76% of companies Debt: 0.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.9%), Puma Biotechnology, Inc. would be worth roughly what it owes.
Total debt $4.8M against a stock market value of $560.1M.
Distance to default 8.78 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.4M (short-term plus half of long-term), stock volatility 60.8%; Altman Z'' -14.50. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.6 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 52.8%  ·  5Y Avg: 13.5%
Cost Advantage ★
63
Intangibles
44
Switching Cost
43
Network Effect
38
Scale
37
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PBYI shows a Weak competitive edge (45.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 52.8% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 8Sell: 4Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A+
Oct 27, 2026
DCF
5
ROE
5
ROA
5
D/E
4
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PBYI receives an overall rating of A+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5), D/E (4/5). Areas of concern: P/B (2/5).
Rating Change History
DateFromTo
2026-10-27 A A+
2026-10-26 A+ A
2026-10-22 A A+
2026-08-14 A+ A
2026-08-04 A A+
2026-07-30 A+ A
2026-07-01 A A+
2026-05-18 A+ A
2026-05-08 A A+
2026-05-06 A+ A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 45 Grade A+
Profitability
71
Balance Sheet
96
Earnings Quality
70
Growth
20
Value
50
Momentum
53
Safety
0
Cash Flow
76
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PBYI scores highest in Balance Sheet (96/100) and lowest in Safety (0/100). An overall grade of A+ places PBYI among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.18
Distress Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✓ ✓ ✗ ✓ ✗
Beneish M-Score
-2.64
Unlikely Manipulator
Ohlson O-Score
-9.64
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 60.6/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.54x
Accruals: -7.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PBYI scores -2.18, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PBYI scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PBYI's score of -2.64 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PBYI's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PBYI receives an estimated rating of BBB+ (score: 60.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PBYI's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
20.29x
PEG
-0.45x
P/S
2.43x
P/B
4.00x
P/FCF
10.36x
P/OCF
10.37x
EV/EBITDA
7.49x
EV/Revenue
1.46x
EV/EBIT
9.73x
EV/FCF
8.20x
Earnings Yield
6.26%
FCF Yield
9.65%
Shareholder Yield
0.00%
Graham Number
$5.49
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 20.3x earnings, PBYI commands a growth premium. An earnings yield of 6.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $5.49 per share, 99% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.857
NI / EBT
×
Interest Burden
0.899
EBT / EBIT
×
EBIT Margin
0.150
EBIT / Rev
×
Asset Turnover
1.193
Rev / Assets
×
Equity Multiplier
1.594
Assets / Equity
=
ROE
22.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PBYI's ROE of 22.0% is driven by Asset Turnover (1.193), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$4.32
Price/Value
1.88x
Margin of Safety
-87.83%
Premium
87.83%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PBYI's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. PBYI trades at a 88% premium to its adjusted intrinsic value of $4.32, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 20.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$10.92
Median 1Y
$8.12
5th Pctile
$2.16
95th Pctile
$30.58
Ann. Volatility
77.5%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Alan H. Auerbach
President and Chief Executive Officer
 $931,333 $551,549 $3,062,337
Jeff J. Ludwig
Chief Commercial Officer
 $264,880 $132,998 $1,476,167
Maximo F. Nougues
Chief Financial Officer
 $562,961 $170,848 $1,241,215
Douglas Hunt, B.Sc.
(Hons) Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer
 $489,060 $133,765 $1,061,400

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,062,337
Avg Employee Cost (SGA/emp): $395,793
Employees: 179

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
179
+4.1% YoY
Revenue / Employee
$1,275,816
Rev: $228,371,000
Profit / Employee
$173,804
NI: $31,111,000
SGA / Employee
$395,793
Avg labor cost proxy
R&D / Employee
$346,749
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 8.5% 6.9% -4.2% -1.4% 1.8% 0.0% 29.1% -9.7% 12.2% 57.5% 40.0% 22.1% 42.3% 41.6% 51.4% 63.2% 39.7% 28.0% 21.6% 22.0% 21.97%
ROA -19.8% -12.3% -21.3% -15.2% 4.6% 0.0% 2.4% -1.2% 1.8% 9.5% 7.5% 4.3% 11.0% 13.6% 18.6% 24.2% 17.5% 14.5% 12.5% 13.8% 13.78%
ROIC -70.1% -71.5% -79.9% -22.5% -16.1% 0.2% 37.8% 24.8% 34.5% 45.0% 44.3% 32.6% 50.3% 59.6% 67.6% 91.1% 64.8% 52.9% 57.7% 52.8% 52.75%
ROCE -31.1% -13.6% -29.1% -16.8% 15.3% 8.3% 11.9% 7.9% 12.5% 26.3% 24.5% 21.8% 33.6% 31.2% 39.5% 44.9% 32.5% 31.4% 25.8% 24.3% 24.27%
Gross Margin 77.8% 78.5% 76.3% 74.9% 78.1% 74.4% 75.0% 78.3% 76.3% 66.3% 75.5% 77.4% 63.9% 76.4% 77.1% 76.5% 77.7% 69.3% 76.7% 77.9% 77.92%
Operating Margin -19.4% -42.6% -1.6% 20.3% 4.2% 15.3% 8.3% 9.0% 15.3% 20.5% -5.3% -4.6% 27.4% 22.6% 8.7% 12.7% 17.6% 22.7% -8.5% 13.4% 13.42%
Net Margin -96.6% 7.6% -7.4% 15.7% -0.6% -8.5% 2.7% 3.9% 10.3% 17.0% -11.0% -9.6% 25.2% 32.7% 6.5% 11.2% 16.2% 17.8% -8.4% 14.5% 14.49%
EBITDA Margin -84.5% 17.0% 3.8% 24.5% 9.0% 0.3% 14.7% 15.6% 20.4% 25.4% 3.8% 4.5% 33.0% 30.0% 17.9% 20.5% 24.7% 27.7% -0.4% 19.4% 19.36%
FCF Margin 4.2% 8.2% -10.9% -17.3% -13.3% -10.0% -2.5% 4.9% 2.0% 6.1% 15.7% 15.2% 13.8% 16.9% 13.4% 18.6% 20.2% 18.3% 23.6% 17.8% 17.80%
OCF Margin 8.2% 8.2% -10.9% -17.3% -13.3% -6.9% 5.8% 13.4% 10.6% 11.5% 15.7% 15.2% 13.9% 16.9% 13.4% 18.6% 20.3% 18.3% 23.6% 17.8% 17.79%
ROE 3Y Avg snapshot only 27.84%
ROE 5Y Avg snapshot only -19.84%
ROA 3Y Avg snapshot only 14.32%
ROIC 3Y Avg snapshot only 43.92%
ROIC Economic snapshot only 18.81%
Cash ROA snapshot only 21.35%
Cash ROIC snapshot only 83.20%
CROIC snapshot only 83.22%
NOPAT Margin snapshot only 11.28%
Pretax Margin snapshot only 13.48%
R&D / Revenue snapshot only 30.90%
SGA / Revenue snapshot only 30.78%
SBC / Revenue snapshot only 3.09%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -5.93 -4.30 -2.48 -3.75 10.98 96897.00 30.32 -68.31 33.83 9.63 16.61 18.05 5.40 4.98 3.88 3.55 7.31 9.85 13.32 15.97 20.291
P/S Ratio 1.14 0.49 0.61 0.62 0.50 0.85 0.62 0.72 0.55 0.88 1.13 0.72 0.51 0.65 0.63 0.72 1.28 1.34 1.43 1.84 2.429
P/B Ratio -26.20 -51.01 17.01 6.55 4.87 8.97 5.64 5.48 3.25 3.89 5.01 3.25 1.76 1.64 1.52 1.64 2.35 2.35 2.53 3.08 4.000
P/FCF 27.44 6.04 -5.55 -3.62 -3.73 -8.49 -25.17 14.73 27.09 14.48 7.20 4.73 3.72 3.88 4.74 3.89 6.31 7.35 6.06 10.36 10.364
P/OCF 13.99 6.04 — — — — 10.63 5.40 5.19 7.70 7.17 4.72 3.71 3.87 4.72 3.88 6.29 7.33 6.06 10.37 10.366
EV/EBITDA -13.73 -30.08 -6.18 -13.83 4.69 10.49 6.81 9.52 5.48 4.86 6.48 4.74 2.36 2.58 2.13 1.98 4.33 4.45 5.33 7.49 7.486
EV/Revenue 1.26 0.63 0.82 0.89 0.67 1.00 0.80 0.89 0.67 0.95 1.14 0.73 0.47 0.54 0.50 0.53 1.02 1.04 1.05 1.46 1.459
EV/EBIT -9.21 -10.02 -4.47 -8.02 6.83 18.84 10.68 18.45 8.97 6.48 9.12 7.24 3.10 3.39 2.69 2.41 5.56 5.60 6.98 9.73 9.729
EV/FCF 30.28 7.71 -7.47 -5.15 -5.01 -9.94 -32.50 18.13 32.95 15.56 7.30 4.79 3.42 3.19 3.73 2.83 5.06 5.69 4.47 8.20 8.199
Earnings Yield -16.9% -23.3% -40.3% -26.7% 9.1% 0.0% 3.3% -1.5% 3.0% 10.4% 6.0% 5.5% 18.5% 20.1% 25.8% 28.2% 13.7% 10.1% 7.5% 6.3% 6.26%
FCF Yield 3.6% 16.5% -18.0% -27.6% -26.8% -11.8% -4.0% 6.8% 3.7% 6.9% 13.9% 21.1% 26.9% 25.8% 21.1% 25.7% 15.9% 13.6% 16.5% 9.6% 9.65%
Price/Tangible Book snapshot only 4.181
EV/OCF snapshot only 8.201
EV/Gross Profit snapshot only 1.950
Acquirers Multiple snapshot only 11.088
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $5.49
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.18 1.28 1.57 2.01 2.04 1.73 2.32 1.97 1.86 1.57 1.46 1.32 1.42 1.54 1.53 1.73 1.74 2.00 2.38 2.91 2.912
Quick Ratio 1.12 1.21 1.47 1.89 1.95 1.67 2.24 1.84 1.78 1.50 1.38 1.23 1.40 1.45 1.43 1.62 1.62 1.93 2.24 2.64 2.644
Debt/Equity -10.73 -47.69 16.25 5.85 5.19 5.29 4.40 3.72 2.90 2.09 2.17 2.03 1.21 0.80 0.64 0.47 0.36 0.22 0.12 0.03 0.035
Net Debt/Equity — — 5.90 2.77 1.67 1.54 1.64 1.27 0.70 0.29 0.07 0.04 -0.15 -0.29 -0.32 -0.45 -0.46 -0.53 -0.67 -0.64 -0.643
Debt/Assets 0.52 0.51 0.58 0.60 0.58 0.51 0.58 0.56 0.55 0.48 0.52 0.48 0.39 0.35 0.31 0.25 0.20 0.13 0.08 0.02 0.025
Debt/EBITDA -5.10 -22.02 -4.38 -8.68 3.72 5.28 4.11 5.24 4.02 2.42 2.77 2.94 1.77 1.54 1.13 0.78 0.82 0.54 0.36 0.11 0.107
Net Debt/EBITDA -1.29 -6.52 -1.59 -4.12 1.20 1.53 1.54 1.79 0.98 0.34 0.09 0.05 -0.21 -0.56 -0.58 -0.74 -1.06 -1.29 -1.91 -1.98 -1.976
Interest Coverage -2.51 -1.24 -3.05 -2.05 1.93 1.04 1.44 0.86 1.29 2.59 2.12 1.64 2.82 2.94 3.84 5.34 4.81 6.40 6.62 9.86 9.857
Equity Multiplier -20.72 -92.63 28.09 9.81 8.97 10.28 7.59 6.60 5.26 4.31 4.20 4.23 3.10 2.32 2.02 1.86 1.76 1.66 1.50 1.39 1.391
Cash Ratio snapshot only 1.885
Debt Service Coverage snapshot only 12.811
Cash to Debt snapshot only 19.494
FCF to Debt snapshot only 8.544
Defensive Interval snapshot only 327.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 1.03 1.08 0.87 0.91 1.02 1.02 1.18 1.17 1.14 1.04 1.10 1.08 1.15 1.04 1.13 1.19 1.00 1.06 1.17 1.19 1.193
Inventory Turnover 12.12 12.06 5.99 6.71 7.92 9.47 10.29 7.61 9.92 10.80 10.95 7.07 17.91 8.15 8.10 7.47 8.06 8.17 6.65 5.31 5.311
Receivables Turnover 9.83 8.72 7.55 6.41 8.40 6.26 8.08 7.05 8.04 5.34 8.13 7.38 5.83 5.77 9.35 8.81 4.81 5.33 8.82 7.71 7.712
Payables Turnover 3.85 5.48 4.98 4.56 2.87 6.26 7.18 6.17 5.52 9.41 6.86 5.54 11.90 10.39 8.57 6.96 7.05 11.01 8.18 13.65 13.647
DSO 37 42 48 57 43 58 45 52 45 68 45 49 63 63 39 41 76 68 41 47 47.3 days
DIO 30 30 61 54 46 39 35 48 37 34 33 52 20 45 45 49 45 45 55 69 68.7 days
DPO 95 67 73 80 127 58 51 59 66 39 53 66 31 35 43 52 52 33 45 27 26.7 days
Cash Conversion Cycle -28 6 36 31 -38 39 30 41 16 63 25 35 52 73 41 38 69 80 52 89 89.3 days
Fixed Asset Turnover snapshot only 51.126
Operating Cycle snapshot only 116.0 days
Cash Velocity snapshot only 2.463
Capital Intensity snapshot only 0.833
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 6.3% 12.5% -26.2% -18.8% -13.0% -9.9% 17.1% 11.2% 5.2% 3.3% -3.6% -4.8% 6.3% -2.2% 2.7% 8.6% -13.0% -0.9% -2.4% -2.9% -2.86%
Net Income 14.2% 51.6% -84.5% 1.6% 1.2% 1.0% 1.1% 92.9% -62.2% 10794.5% 2.2% 4.6% 5.3% 40.2% 1.5% 4.6% 59.1% 2.8% -35.9% -44.9% -44.86%
EPS 16.5% 53.0% -78.8% 12.2% 1.2% 1.0% 1.1% 93.2% -64.0% 10294.3% 2.1% 4.5% 5.1% 36.3% 1.4% 4.4% 53.6% -1.5% -37.1% -47.4% -47.43%
FCF 36.4% 3.2% -2.2% -22.8% -3.8% -2.1% 73.6% 1.3% 1.2% 1.6% 7.1% 1.9% 6.3% 1.7% -12.1% 33.0% 27.3% 7.4% 72.0% -6.9% -6.93%
EBITDA 31.7% 85.2% -32.4% -50.7% 2.3% 5.1% 2.0% 2.6% -9.7% 1.1% 44.6% 55.8% 74.6% 4.5% 36.8% 88.6% 3.0% 11.0% -17.8% -28.8% -28.77%
Op. Income 40.7% 4.5% -13.5% -7.4% 40.4% 1.8% 1.6% 2.0% 3.8% 37.6% -9.9% -12.7% 16.3% -5.1% 43.4% 1.4% 3.6% 20.5% -20.8% -33.9% -33.93%
OCF Growth snapshot only -7.20%
Asset Growth snapshot only -1.12%
Equity Growth snapshot only 32.30%
Debt Growth snapshot only -90.22%
Shares Change snapshot only 4.89%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 7.5% 0.3% -10.9% -10.3% -8.1% -5.7% 1.6% -1.5% -0.9% 1.5% -5.9% -4.9% -0.9% -3.1% 5.1% 4.8% -0.9% 0.0% -1.1% 0.2% 0.16%
Revenue 5Y — — — — 1.0% 52.5% 20.1% 9.7% 2.6% -1.3% -4.4% -5.2% -2.8% -3.3% 0.7% -0.3% -2.1% 0.3% -3.5% -1.9% -1.93%
EPS 3Y — — — — — — — — — — — — — — — — 49.9% 23.0% 67.6% — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — 55.5% 24.0% 71.8% — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — 17.5% 35.1% 17.6% 27.9% 27.90%
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 2.7% -4.3% -14.3% -14.0% -11.7% -9.8% -1.6% -4.7% -4.0% -2.3% -7.8% -5.9% -3.5% -4.3% 2.7% 2.7% -0.9% -0.5% -1.6% -0.5% -0.51%
Gross Profit 5Y — — — — 1.1% 51.0% 16.7% 7.2% 0.1% -4.4% -7.6% -8.5% -7.1% -6.7% -2.0% -3.2% -3.7% -1.7% -4.4% -2.1% -2.10%
Op. Income 3Y — — — — — — — — — — 86.6% — — — — — — 16.3% 0.8% 12.0% 12.00%
Op. Income 5Y — — — — — — — — — — — — — — — — — — 49.1% — —
FCF 3Y — — — — — — — — -15.3% — 25.5% 1.7% 47.8% 23.5% — — — — — 53.8% 53.80%
FCF 5Y — — — — — — — — — — — 3.8% 3.9% 12.0% 3.2% — 41.2% — 24.5% 90.6% 90.56%
OCF 3Y — — — — — — -20.2% — 44.9% 2.3% 8.4% 41.9% 18.2% 23.5% — — — — 57.5% 10.0% 10.04%
OCF 5Y — — — — — — — — — — — 3.6% 3.9% 11.7% 3.0% — 40.1% 1.2% 13.9% 28.7% 28.66%
Assets 3Y -0.6% -4.4% -15.4% -6.9% -5.0% -1.9% -4.5% -8.7% -8.0% -1.9% -6.1% -7.6% -0.8% -2.0% -0.8% 0.2% 0.7% -0.9% -0.6% -1.3% -1.31%
Assets 5Y 11.0% -2.2% -1.5% 2.3% 1.8% 6.1% 3.0% -2.5% -2.5% -2.3% -8.4% -3.1% -1.0% -1.9% -2.7% -5.9% -5.0% -2.4% -5.7% -5.8% -5.81%
Equity 3Y — — -45.2% -3.2% 8.8% 7.4% 40.2% 9.1% — — 45.8% 18.1% — — 1.4% 74.4% 73.3% 82.0% 70.6% 65.8% 65.80%
Book Value 3Y — — -46.9% -8.2% 3.2% 1.8% 31.9% 3.2% — — 38.1% 11.3% — — 1.3% 68.7% 67.0% 75.0% 66.4% 59.9% 59.92%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.72 0.61 0.44 0.43 0.48 0.53 0.51 0.39 0.20 0.16 0.53 0.72 0.51 0.81 0.16 0.01 0.09 0.20 0.74 0.34 0.345
Earnings Stability 0.86 0.85 0.85 0.84 0.86 0.79 0.79 0.76 0.93 0.99 0.89 0.88 0.91 0.98 0.88 0.89 0.88 0.90 0.73 0.83 0.835
Margin Stability 0.93 0.93 0.94 0.93 0.93 0.94 0.94 0.94 0.94 0.93 0.93 0.93 0.92 0.92 0.94 0.94 0.93 0.95 0.97 0.98 0.977
Rev. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 1.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.94 0.50 0.50 0.99 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.20 0.50 0.84 0.50 0.50 0.50 0.99 0.86 0.82 0.821
Earnings Smoothness — — — — — — — — 0.10 0.00 0.00 — 0.00 0.67 0.15 0.00 0.54 0.97 0.56 0.42 0.422
ROE Trend — — -1.65 -0.26 — — 4.42 1.39 — — 3.63 1.09 0.06 0.13 0.15 0.41 0.11 -0.13 -0.16 -0.13 -0.128
Gross Margin Trend -0.10 -0.10 -0.03 -0.03 -0.02 -0.03 -0.02 0.00 -0.00 -0.02 -0.03 -0.04 -0.07 -0.03 -0.02 -0.02 0.04 0.02 0.02 0.02 0.021
FCF Margin Trend -0.02 0.06 -0.20 -0.17 -0.17 -0.12 -0.00 0.13 0.07 0.07 0.22 0.21 0.19 0.19 0.07 0.09 0.12 0.07 0.09 0.01 0.009
Sustainable Growth Rate — — — — 1.8% 0.0% 29.1% — 12.2% 57.5% 40.0% 22.1% 42.3% 41.6% 51.4% 63.2% 39.7% 28.0% 21.6% 22.0% 21.97%
Internal Growth Rate — — — — 4.9% 0.0% 2.5% — 1.9% 10.5% 8.1% 4.5% 12.3% 15.8% 22.8% 32.0% 21.2% 16.9% 14.3% 16.0% 15.99%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -0.42 -0.71 0.45 1.04 -2.94 -7913.50 2.85 -12.66 6.52 1.25 2.32 3.82 1.45 1.29 0.82 0.92 1.16 1.34 2.20 1.54 1.540
FCF/OCF 0.51 1.00 1.00 1.00 1.00 1.44 -0.42 0.37 0.19 0.53 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.540
OCF/EBITDA snapshot only 0.913
CapEx/Revenue 4.0% 0.0% 0.0% 0.0% 0.0% 3.1% 8.3% 8.5% 8.6% 5.4% 0.1% 0.0% 0.0% 0.0% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.001
Accruals Ratio -0.28 -0.21 -0.12 0.01 0.18 0.07 -0.04 -0.17 -0.10 -0.02 -0.10 -0.12 -0.05 -0.04 0.03 0.02 -0.03 -0.05 -0.15 -0.07 -0.074
Sloan Accruals snapshot only 0.141
Cash Flow Adequacy snapshot only 4114.800
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — 0.0% 0.0% 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — 0.0% 0.0% 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% -8.2% -7.7% -9.3% -6.5% -1.7% -1.5% -2.0% 0.0% 0.0% 0.0% -0.1% -0.1% -0.1% -0.2% -0.0% -0.0% -0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% -8.2% -7.7% -9.3% -6.5% -1.7% -1.5% -2.0% 0.0% 0.0% 0.0% -0.1% -0.1% -0.1% -0.2% -0.0% -0.0% -0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.01 1.01 1.01 0.96 0.00 0.89 1.40 0.82 0.95 0.93 0.87 0.94 1.26 1.19 1.15 1.20 0.87 0.84 0.86 0.857
Interest Burden (EBT/EBIT) 1.40 1.81 1.33 1.49 0.48 0.04 0.30 -0.16 0.27 0.66 0.58 0.46 0.66 0.66 0.74 0.81 0.79 0.84 0.85 0.90 0.899
EBIT Margin -0.14 -0.06 -0.18 -0.11 0.10 0.05 0.07 0.05 0.07 0.15 0.13 0.10 0.15 0.16 0.19 0.22 0.18 0.19 0.15 0.15 0.150
Asset Turnover 1.03 1.08 0.87 0.91 1.02 1.02 1.18 1.17 1.14 1.04 1.10 1.08 1.15 1.04 1.13 1.19 1.00 1.06 1.17 1.19 1.193
Equity Multiplier -42.90 -56.07 19.48 9.22 37.84 23.41 12.03 7.86 6.61 6.03 5.34 5.14 3.86 3.05 2.77 2.61 2.27 1.93 1.72 1.59 1.594
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.18 $-0.71 $-1.16 $-0.76 $0.22 $0.00 $0.10 $-0.05 $0.08 $0.45 $0.32 $0.18 $0.47 $0.61 $0.76 $0.97 $0.73 $0.60 $0.48 $0.51 $0.51
Book Value/Share $-0.27 $-0.06 $0.17 $0.44 $0.49 $0.47 $0.55 $0.64 $0.81 $1.11 $1.06 $1.00 $1.45 $1.86 $1.95 $2.09 $2.26 $2.53 $2.53 $2.63 $2.72
Tangible Book/Share $-1.94 $-1.67 $-1.35 $-0.93 $-0.83 $-1.07 $-0.90 $-0.75 $-0.51 $-0.15 $-0.15 $-0.16 $0.36 $0.83 $0.97 $1.17 $1.40 $1.73 $1.76 $1.94 $1.94
Revenue/Share $6.13 $6.17 $4.76 $4.56 $4.78 $4.98 $4.98 $4.88 $4.79 $4.91 $4.70 $4.54 $4.95 $4.66 $4.66 $4.75 $4.16 $4.43 $4.47 $4.40 $4.54
FCF/Share $0.26 $0.50 $-0.52 $-0.79 $-0.64 $-0.50 $-0.12 $0.24 $0.10 $0.30 $0.74 $0.69 $0.68 $0.79 $0.62 $0.88 $0.84 $0.81 $1.05 $0.78 $0.81
OCF/Share $0.50 $0.50 $-0.52 $-0.79 $-0.64 $-0.35 $0.29 $0.65 $0.51 $0.56 $0.74 $0.69 $0.69 $0.79 $0.63 $0.88 $0.84 $0.81 $1.05 $0.78 $0.81
Cash/Share $2.14 $2.00 $1.75 $1.34 $1.71 $1.77 $1.51 $1.58 $1.78 $2.00 $2.22 $2.01 $1.97 $2.04 $1.87 $1.91 $1.85 $1.89 $2.00 $1.79 $1.84
EBITDA/Share $-0.56 $-0.13 $-0.63 $-0.29 $0.68 $0.47 $0.59 $0.46 $0.58 $0.96 $0.83 $0.69 $0.99 $0.97 $1.10 $1.26 $0.98 $1.04 $0.88 $0.86 $0.86
Debt/Share $2.87 $2.84 $2.75 $2.55 $2.52 $2.49 $2.41 $2.39 $2.35 $2.32 $2.30 $2.04 $1.76 $1.50 $1.24 $0.98 $0.81 $0.55 $0.31 $0.09 $0.09
Net Debt/Share $0.73 $0.84 $1.00 $1.21 $0.81 $0.72 $0.90 $0.82 $0.57 $0.32 $0.07 $0.04 $-0.21 $-0.54 $-0.63 $-0.93 $-1.05 $-1.34 $-1.68 $-1.69 $-1.69
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -2.183
Altman Z-Prime snapshot only -8.923
Piotroski F-Score 4 4 3 1 4 4 6 6 5 6 6 5 6 7 7 6 7 6 5 6 6
Beneish M-Score -4.03 -3.26 -2.64 -2.28 -1.29 -1.82 -2.51 -3.36 -2.98 -2.40 -3.21 -3.22 -1.91 -3.11 -2.29 -2.41 -3.20 -2.18 -3.25 -2.64 -2.636
Ohlson O-Score snapshot only -9.637
ROIC (Greenblatt) snapshot only 34.77%
Net-Net WC snapshot only $1.73
EVA snapshot only $21144711.04
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 20.00 20.00 17.86 19.99 23.44 17.60 22.40 21.05 23.99 35.85 36.73 34.17 41.06 46.99 51.46 57.63 54.32 57.31 58.32 60.62 60.620
Credit Grade snapshot only 8
Credit Trend snapshot only 2.990
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 56
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms